NovoCure Limited (NVCR)
NovoCure Statistics
Share Statistics
NovoCure has 111.49M shares outstanding. The number of shares has increased by 2.14% in one year.
| 111.49M |
| 2.14% |
| 1.58% |
| 84.62% |
| n/a |
| 621 |
| 0.06% |
Short Selling Information
The latest short interest is 5.4M, so 4.84% of the outstanding shares have been sold short.
| 5.4M |
| 4.84% |
| 7.66% |
| 6.17 |
Valuation Ratios
The PE ratio is -19.06 and the forward PE ratio is -9.56. NovoCure's PEG ratio is 0.95.
| -19.06 |
| -9.56 |
| 5.31 |
| 1.6 |
| 8.92 |
| -46.42 |
| 0.95 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for NovoCure.
| n/a |
| n/a |
| n/a |
| n/a |
Financial Position
The company has a current ratio of 1.46, with a Debt / Equity ratio of 1.9.
| 1.46 |
| 1.42 |
| 1.9 |
| -6.31 |
| -9.87 |
| -16.48 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| n/a |
| n/a |
| n/a |
| $406,733.87 |
| $-113,324.6 |
| 1,488 |
| 0.49 |
| 3.91 |
Taxes
| 37.47M |
| -28.56% |
Stock Price Statistics
The stock price has increased by -25.82% in the last 52 weeks. The beta is 0.75, so NovoCure's price volatility has been higher than the market average.
| 0.75 |
| -25.82% |
| 17.53 |
| 20.21 |
| 38.72 |
| 970,507 |
Income Statement
In the last 12 months, NovoCure had revenue of 605.22M and earned -168.63M in profits. Earnings per share was -1.56.
| 605.22M |
| 468.04M |
| -170.5M |
| -168.63M |
| -108.26M |
| -120.82M |
| -1.56 |
Balance Sheet
The company has 163.77M in cash and 683.35M in debt, giving a net cash position of -519.59M.
| 163.77M |
| 683.35M |
| -519.59M |
| -1.15B |
| 1.25B |
| 346M |
Cash Flow
In the last 12 months, operating cash flow was -26.37M and capital expenditures -42.85M, giving a free cash flow of -69.22M.
| -26.37M |
| -42.85M |
| -69.22M |
| -0.64 |
Margins
Gross margin is 77.33%, with operating and profit margins of -28.17% and -27.86%.
| 77.33% |
| -28.17% |
| -21.67% |
| -27.86% |
| -17.89% |
| -28.17% |
| -11.44% |
Dividends & Yields
NVCR does not appear to pay any dividends at this time.
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
Analyst Forecast
The average price target for NVCR is $32, which is 94.8% higher than the current price. The consensus rating is "Buy".
| $32 |
| 94.8% |
| Buy |
| 6 |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| n/a |
| n/a |
| n/a |
| n/a |
Scores
| 0.65 |
| 3 |